Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Former employee defrauds K2fly out of $745k as investigation continues
    • News

    Former employee defrauds K2fly out of $745k as investigation continues

    Mining tech company K2fly (ASX: K2F) is set to incur a substantial loss for the year, having uncovered suspicious payments totalling $745k in a case of suspected fraud committed by a former employee in their South Africa office.  Investigations are ongoing but upon initial concerns in accounting discrepancies, K2fly engaged external auditors which have now

    Read More
    Public
  • A tale of investment advice, Equity Story seeks $4.5m for IPO chapter
    • News

    A tale of investment advice, Equity Story seeks $4.5m for IPO chapter

    In an IPO slated to list on 18 March 2022, Equity Story Group (proposed ASX code: EQS) is looking to raise $4.5 million to fund their expansion in the burgeoning share market education and investment advice space, coming up against industry stalwarts like Eureka Report, Switzer, Halo Technologies, and Motley Fool. Equity Story is differentiating

    Read More
    Public
  • Out-the-box thinkers are just what the myelofibrosis treatment market needs
    • News

    Out-the-box thinkers are just what the myelofibrosis treatment market needs

    The pharmaceutical industry is an incredibly competitive space with new drug discoveries cropping up all the time, giving hope that we may soon find resolutions to the complicated medical challenges of today.  The competitive nature of the space means that whoever is first to market has a clear advantage. Clinical stage pharmaceutical company Pharmaxis (ASX:

    Read More
    Public
  • Here’s how Bio-Gene is keeping your muesli bug free
    • News

    Here’s how Bio-Gene is keeping your muesli bug free

    The range of creepy crawlies that find their way into Australian grain stores is broad enough to make you rethink your morning oats. I mean, no one likes the taste of flour beetles or weevils in their brekkie. Agricultural technology development company Bio-Gene Technology (ASX: BGT) agrees, and are working on solutions to common pests

    Read More
    Public
  • Sprintex engaged to develop next gen air compressors for hydrogen fuel cells
    • News

    Sprintex engaged to develop next gen air compressors for hydrogen fuel cells

    Like many developments in the world of engineering, there’s nothing particularly sexy about air compressors but as the world moves towards clean energy adoption, they are vital cogs in fuel cells, which is just one reason Sprintex (ASX: SIX) has been engaged to develop an innovative new design.  The engagement comes from existing technology partner

    Read More
    Public
  • Monthly Global Wrap – Economic and stock news you should be aware of
    • Opinion

    Monthly Global Wrap – Economic and stock news you should be aware of

    Global Markets Update: US markets. US markets declined in the month, with the Dow Jones down -3.5%and S&P 500 down -3.1%. Long-dated US treasury yields higher, with the 2-Yr yield at 1.44% and 10-Yr yield at 1.83%. European markets. European markets declined with the Stoxx Europe 600 Index down -3.4% and German DAX down -6.5%, as

    Read More
    Public
  • «
  • ‹
  • 401
  • 402
  • 403
  • 404
  • 405
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.